Salivary gland epithelial cells (SGEC): Carriers of exquisite B7-2 (CD86) costimulatory molecules

被引:12
作者
Kapsogeorgou, Efstathia K. [1 ]
Manoussakis, Menelaos N. [1 ]
机构
[1] Natl Univ Athens, Dept Pathophysiol, Sch Med, Athens 11527, Greece
关键词
Salivary gland epithelial cells; B7-2 (CD86) costimulatory molecules; B7-2 (CD86) alternate transcripts; Sjogren's syndrome; HUMAN T-LYMPHOCYTES; SPLICE VARIANT; FUNCTIONAL EXPRESSION; AUTOIMMUNE-DISEASE; SJOGRENS-SYNDROME; IMMUNE-RESPONSES; CTLA-4; CD28; LIGANDS; ACTIVATION;
D O I
10.1016/j.jaut.2010.06.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Costimulatory molecules are cell-surface glycoproteins that can direct, modulate and fine tune immune responses. B7-2(CD86) costimulatory molecules are considered as major regulators of T cell responses, acting by appropriate interactions with the stimulatory CD28 or inhibitory CTLA-4 receptors found on T cells. Although their expression is thought to be restricted in lymphoid cells, evidence raised during the last decade show their expression in other types of cells, including human non-neoplastic salivary gland epithelial cells (SGEC). The expression of B7-2 molecules by SGECs requires special attention, due to their unique expression pattern and distinctive binding properties. Thus, SGECs express three B7-2 alternate transcripts that encode the full-length protein, the soluble form and a truncated membrane-bound molecule, that lacks the IgV-like counter-receptor binding domain and has a negative regulatory role. A similar pattern of expression is observed in monocytes, but not in several other types of cells, including dendritic cells. Furthermore, the full-length B7-2 molecules in SGEC display unique binding properties, denoted by the functional interaction with CD28 receptor, but reduced binding of the negative regulator CTLA-4. These distinctive features suggest the tight regulation of B7-2 molecules expression and indicate the key immunoregulatory role of SGECs. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:188 / 191
页数:4
相关论文
共 49 条
[31]  
2-X
[32]  
MANOUSSAKIS MN, 2010, J AUTOIMMUN
[33]   Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies [J].
Murata, K ;
Dalakas, MC .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (02) :453-460
[34]   Functional expression of costimulatory molecule CD88 on epithelial cells in the inflamed colonic mucose [J].
Nakazawa, A ;
Watanabe, M ;
Kanai, T ;
Yajima, T ;
Yamazaki, M ;
Ogata, H ;
Ishii, H ;
Azuma, M ;
Hibi, T .
GASTROENTEROLOGY, 1999, 117 (03) :536-545
[35]   B7-1 (CD80) and B7-2 (CD86) expression in human tubular epithelial cells in vivo and in vitro [J].
Niemann-Masanek, U ;
Mueller, A ;
Yard, BA ;
Waldherr, R ;
van der Woude, FJ .
NEPHRON, 2002, 92 (03) :542-556
[36]   B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse [J].
Pentcheva-Hoang, T ;
Egen, JG ;
Wojnoonski, K ;
Allison, JP .
IMMUNITY, 2004, 21 (03) :401-413
[37]   Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation [J].
Salomon, B ;
Bluestone, JA .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :225-252
[38]   What's the difference between CD80 and CD86? [J].
Sansom, DM ;
Manzotti, CN ;
Zheng, Y .
TRENDS IN IMMUNOLOGY, 2003, 24 (06) :314-319
[39]   Structural basis for co-stimulation by the human CTLA-4/B7-2 complex [J].
Schwartz, JCD ;
Zhang, XW ;
Fedorov, AA ;
Nathenson, SG ;
Almo, SC .
NATURE, 2001, 410 (6828) :604-608
[40]   Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy [J].
Seko, Y ;
Takahashi, N ;
Ishiyama, S ;
Nishikawa, T ;
Kasajima, T ;
Hiroe, M ;
Suzuki, S ;
Ishiwata, S ;
Kawai, S ;
Azuma, M ;
Yagita, H ;
Okumura, K ;
Yazaki, Y .
CIRCULATION, 1998, 97 (07) :637-639